Literature DB >> 18799236

National influences on catheter-associated bloodstream infection rates: practices among national surveillance networks participating in the European HELICS project.

S Hansen1, F Schwab, M Behnke, H Carsauw, P Heczko, I Klavs, O Lyytikäinen, M Palomar, I Riesenfeld Orn, A Savey, E Szilagyi, R Valinteliene, J Fabry, P Gastmeier.   

Abstract

This study was performed to evaluate associations between organisational characteristics, routine practices and the incidence densities of central venous catheter-associated bloodstream infections (CVC-BSI rates) in European intensive care units (ICUs) as part of the HELICS project (Hospitals in Europe Link for Infection Control through Surveillance). Questionnaires were sent to ICUs participating in the national nosocomial infection surveillance networks in 2004. The national networks were asked for the CVC-BSI rates of the ICUs participating for the time period 2003--2004. Univariate and multivariate risk factor analyses were performed to identify which practices had the greatest impact on CVC-BSI rates. A total of 526 ICUs from 10 countries sent data on organisational characteristics and practices, demonstrating wide variation in care. CVC-BSI rates were also provided for 288 ICUs from five countries. This made it possible to include 1383444 patient days, 969897 CVC days and 1935 CVC-BSI cases in the analysis. Adjusted logistic regression analysis showed that the categorical variables of country [odds ratio (OR) varying per country from OR: 2.3; 95% confidence interval (CI): 0.5-10.2; to OR: 12.8; 95% CI: 4.4-37.5; in reference to the country with the lowest CVC-BSI rates] and type of hospital 'university' (OR: 2.08; 95% CI: 1.02-4.25) were independent risk factors for high CVC-BSI rates. Substantial variation existed in CVC-BSI prevention activities, surveillance methods and estimated CVC-BSI rates among the European countries. Differences in cultural, social and legal perspectives as well as differences between healthcare systems are crucial in explaining these differences.

Entities:  

Mesh:

Year:  2008        PMID: 18799236     DOI: 10.1016/j.jhin.2008.07.014

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  17 in total

1.  Intervention to reduce catheter-related bloodstream infections in a pediatric intensive care unit.

Authors:  Corsino Rey; Francisco Alvarez; Victoria De-La-Rua; Andrés Concha; Alberto Medina; Juan-José Díaz; Sergio Menéndez; Marta Los-Arcos; Juan Mayordomo-Colunga
Journal:  Intensive Care Med       Date:  2011-01-27       Impact factor: 17.440

2.  [Less blood culture samples: less infections?].

Authors:  P Gastmeier; F Schwab; M Behnke; C Geffers
Journal:  Anaesthesist       Date:  2011-08-28       Impact factor: 1.041

3.  Methicillin-resistant Staphylococcus aureus (MRSA) in Europe: which infection control measures are taken?

Authors:  S Hansen; F Schwab; A Asensio; H Carsauw; P Heczko; I Klavs; O Lyytikäinen; M Palomar; I Riesenfeld-Orn; A Savey; E Szilagyi; R Valinteliene; J Fabry; P Gastmeier
Journal:  Infection       Date:  2010-03-16       Impact factor: 3.553

Review 4.  Bacterial sepsis : Diagnostics and calculated antibiotic therapy.

Authors:  D C Richter; A Heininger; T Brenner; M Hochreiter; M Bernhard; J Briegel; S Dubler; B Grabein; A Hecker; W A Kruger; K Mayer; M W Pletz; D Storzinger; N Pinder; T Hoppe-Tichy; S Weiterer; S Zimmermann; A Brinkmann; M A Weigand; C Lichtenstern
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

5.  Prevention of hospital infections by intervention and training (PROHIBIT): results of a pan-European cluster-randomized multicentre study to reduce central venous catheter-related bloodstream infections.

Authors:  Tjallie van der Kooi; Hugo Sax; Didier Pittet; Jaap van Dissel; Birgit van Benthem; Bernhard Walder; Vanessa Cartier; Lauren Clack; Sabine de Greeff; Martin Wolkewitz; Stefanie Hieke; Hendriek Boshuizen; Jan van de Kassteele; Annemie Van den Abeele; Teck Wee Boo; Magda Diab-Elschahawi; Uga Dumpis; Camelia Ghita; Susan FitzGerald; Tatjana Lejko; Kris Leleu; Mercedes Palomar Martinez; Olga Paniara; Márta Patyi; Paweł Schab; Annibale Raglio; Emese Szilágyi; Mirosław Ziętkiewicz; Albert W Wu; Hajo Grundmann; Walter Zingg
Journal:  Intensive Care Med       Date:  2017-12-16       Impact factor: 17.440

Review 6.  [Bacterial sepsis : Diagnostics and calculated antibiotic therapy].

Authors:  D C Richter; A Heininger; T Brenner; M Hochreiter; M Bernhard; J Briegel; S Dubler; B Grabein; A Hecker; W A Krüger; K Mayer; M W Pletz; D Störzinger; N Pinder; T Hoppe-Tichy; S Weiterer; S Zimmermann; A Brinkmann; M A Weigand; Christoph Lichtenstern
Journal:  Anaesthesist       Date:  2017-10       Impact factor: 1.041

7.  A multicentre analysis of catheter-related infection based on a hierarchical model.

Authors:  J F Timsit; F L'Hériteau; A Lepape; A Francais; S Ruckly; A G Venier; P Jarno; S Boussat; B Coignard; A Savey
Journal:  Intensive Care Med       Date:  2012-07-14       Impact factor: 17.440

8.  Implementation of infection control best practice in intensive care units throughout Europe: a mixed-method evaluation study.

Authors:  Hugo Sax; Lauren Clack; Sylvie Touveneau; Fabricio da Liberdade Jantarada; Didier Pittet; Walter Zingg
Journal:  Implement Sci       Date:  2013-02-19       Impact factor: 7.327

9.  Concordance between European and US case definitions of healthcare-associated infections.

Authors:  Sonja Hansen; Dorit Sohr; Christine Geffers; Pascal Astagneau; Alexander Blacky; Walter Koller; Ingrid Morales; Maria Luisa Moro; Mercedes Palomar; Emese Szilagyi; Carl Suetens; Petra Gastmeier
Journal:  Antimicrob Resist Infect Control       Date:  2012-08-02       Impact factor: 4.887

10.  Variations in catheter-related bloodstream infections rates based on local practices.

Authors:  Soraya Cherifi; Georges Mascart; Anne Dediste; Marie Hallin; Michèle Gerard; Marie-Laurence Lambert; Baudouin Byl
Journal:  Antimicrob Resist Infect Control       Date:  2013-04-03       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.